FDA authorizes first fully interoperable continuous glucose monitoring system, streamlines review pathway for similar devices - FDA Press Releases

The authorization classifies integrated continuous glucose monitoring devices in class II and subjects them to certain criteria called special controls

from Food and Drug Administration--Press Releases https://ift.tt/2GcaeLD
via IFTTT